Dottorato in Medicina Molecolare

1.  E. Penna, F. Orso, D. Cimino, E. Tenaglia, A. Lembo, E. Quaglino, L. Poliseno, A. Haimovic, S. Osella, C. De Pittà, E. Pinatel, M. Stadler, P. Provero, M.G. Bernengo,I. Osman and D. Taverna

microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C

The EMBO Journal, May 18, 2011, Vol. 30, N. 10, pp. 1990 – 2007

 2.  F. Orso, E. Penna, D. Cimino, E. Astanina, F. Maione, D. Valdembri, E. Giraudo, G. Serini, P. Sismondi, M. De Bortoli and D. Taverna

AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs

The FASEB Journal, April 28, 2008, Vol. 22, pp. 2702-2714

 3.  F. Orso, M. Fassetta , E. Penna , A. Solero, K. De Filippo , P. Sismondi, M. De Bortoli and D. Taverna

The AP-2alpha transcription factor regulates tumor cell migration and apoptosis.

Advances in Experimental Medicine and Biology, 2007, Vol. 604, pp. 87-95

 

Posters and Abstracts

Talks:

1.  E. Penna, F. Orso, D. Cimino, E. Tenaglia, C. De Pittà, S. Casara, A. Lembo, E. Pinatel, E. Quaglino, S. Osella, G. Lanfranchi, M.G.   Bernengo, P. Provero and D. Taverna

microRNA-214 promotes melanoma tumor progression. 

Selected for oral presentation, ABCD Meeting Mechanisms of Signal Transduction, Firenze, March 26-27, 2010 

2. E. Penna, F. Orso, D. Cimino, E. Tenaglia, A. Lembo, E. Quaglino, L. Poliseno, A. Haimovic, S. Osella, C. De Pittà, E. Pinatel, M. Stadler, P. Provero, M.G. Bernengo,I. Osman and D. Taverna

microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C.

Selected for oral presentation, 3rd Melanoma Workshop, IFOM-IEO Campus, Milan, June 30/July 2, 2011 

3. E. Penna, F. Orso, D. Cimino, E. Tenaglia, A. Lembo, E. Quaglino, L. Poliseno, A. Haimovic, S. Osella, C. De Pittà, E. Pinatel, M. Stadler, P. Provero, MG. Bernengo,I. Osman, D. Taverna

microRNA-214 coordinates melanoma tumor progression via a novel pathway

Selected for oral presentation, ABCD/SIBBM Joint National Ph.D. Meeting, Gubbio, October 20-22, 2011

Posters:

1.  F. Orso, D. Corà, E. Penna, D. Cimino, M. De Bortoli, D. Taverna and M. Caselle. Identification of new AP-2a regulated genes: a biological and bioinformatic approach. BITS 2007 Meeting.  Napoli, April 26-28, 2007

 2.  F. Orso, E. Penna, A. Solero, P. Sismondi, M. De Bortoli and D. Taverna. The AP-2alpha transcription factor regulates tumor cell migration. “SEMM  Workshop on Cell Migration: from Molecules to Organisms and Diseases”. IFOM-IEO Campus, Milano, May 12-14, 2007

 3.   E. Penna, F. Orso, P. Sismondi, M. De Bortoli, D. Taverna. The AP-2alpha transcription factor regulates apoptosis in epithelial tumor cells. “Molecular Determinants of Cell Signaling” - Terzo Seminario Nazionale SIBBM, Torino, June 25-27, 2007

 4.   F. Orso, D. Corà, E. Penna, D. Cimino, M. De Bortoli, D. Taverna and M. Caselle. Identification of new AP-2a regulated genes: a biological and bioinformatic approach. 15th Annual International Conference on Intelligent Systems for Molecular Biology (ISMB) & 6th European Conference on Computational Biology (ECCB). Vienna, July 21-25, 2007

 5.   E. Penna, F. Orso, P. Sismondi, M. De Bortoli, D. Taverna. AP-2alpha and AP-2gamma regulate chemotherapy-induced apoptosis in epithelial tumors. IX Annual Congress FISV 2007, Riva del Garda, September 26-29, 2007

 6.   F. Orso, E. Penna, D. Corà, M. Caselle, P. Sismondi, M. De Bortoli, D. Taverna. The AP-2alpha and AP-2gamma transcription factors regulate tumor formation and progression via a specific genetic program. “Oncogenes and human cancer: the next 25 years”, Madrid, October 3-6, 2007   

 7.   F. Orso, E. Penna, D. Corà, M. Caselle, P. Sismondi, M. De Bortoli, D. Taverna

The AP-2alpha and AP-2gamma transcription factors regulate tumor formation and progression via a specific genetic program ABCD Meeting, Certosa di Pontignano, 28-29 marzo 2008; Selected for oral presentation

 8.   F. Orso, E. Penna, D. Corà, M. Caselle, P. Sismondi, M. De Bortoli, D. Taverna. The AP-2alpha and AP-2gamma transcription factors regulate tumor formation and progression via a specific genetic program. Mammary Gland Gordon Conference, Il Ciocco, Barga, Lucca, June 1-6, 2008

 9.  E. Penna, D. Cimino, F. Orsoand D. Taverna. Identification and characterization of microRNAs involved in tumour progression and metastasis^. Riunione nazionale dottorandi ABCD, Rimini, June 5, 2008

 10.  F. Orso, E. Penna,D. Cimino, E. Tenaglia, A. Lembo, E. Pinatel, P. Provero, D. Taverna.microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C. EMBO/EMBL Symposium The Non Coding Genome, Heidelberg, October 13-16, 2010

 11. E. Penna, F. Orso, D. Cimino, E. Tenaglia, A. Lembo, E. Quaglino, L. Poliseno, S. Osella, C. De Pittà, E. Pinatel, P. Provero, M.G. Bernengo,I. Osman, D. Taverna. microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C. Metafight Workshop: Unravelling Cancer Cell Invasion and Metastasis, Torino, December 2-3, 2010.  Poster prize

 12. F. Orso, E. Penna, A. Mana, M. Stadler, A. Lembo, P. Provero, D. Taverna. Modulations of miR-214 in tumor cells. Metafight Workshop: Unravelling Cancer Cell Invasion and Metastasis, Torino, December 2-3, 2010.

 13. E. Penna, F. Orso, D. Cimino, E. Tenaglia, A. Lembo, E. Quaglino, L. Poliseno, S. Osella, C. De Pittà, E. Pinatel, P. Provero, M.G. Bernengo,I. Osman, D. Taverna. microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C. ICC Metastasis and Angiogenesis Conference, Barcelona, May, 26-27, 2011

 14. E. Penna, F. Orso, D. Cimino, E. Tenaglia, A. Lembo, E. Quaglino, L. Poliseno, A. Haimovic, S. Osella, C. De Pittà, E. Pinatel, M. Stadler, P. Provero, M.G. Bernengo,I. Osman and D. Taverna. microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C. 36th FEBS Congress, Torino, June 25 - 30, 2011

15. E. Penna, F. Orso, D. Cimino, E. Tenaglia, A. Lembo, E. Quaglino, L. Poliseno, A. Haimovic, S. Osella, C. De Pittà, E. Pinatel, M. Stadler, P. Provero, M.G. Bernengo,I. Osman and D. Taverna. microRNA-214 controls a novel pathway that coordinate melanoma tumor progression. ISREC Symposium Hallmarks and Horizons of Cancer, Lausanne, September 7-10, 2011

 

Anno 2009

Meeting ABCD Mechanisms of Signal Transduction

Certosa di Pontignano (SI), 20-21 marzo 2009

 Anno 2010

Meeting ABCD Mechanisms of Signal Transduction Fiesole (FI), 26-27 marzo 2010

 MBC/EuroClone Meeting New Challenges in Stem Cell Research Torino, 5 luglio 2010

 MetaFight International Workshop Unravelling Cancer Cell Invasion and Metastasis Torino, 2-3 dicembre 2010

 Anno 2011

3rd Melanoma Workshop IFOM-IEO Campus, Milano, 30 giugno-2 luglio 2011

36th FEBS Congress Torino, 25-30 giugno 2011

 ISREC Symposium Hallmarks and Horizons of Cancer, Losanna (Svizzera), 7-10 settembre 2011

 ABCD/SIBBM Joint National Ph.D. Meeting Gubbio (PG), 20-22 ottobre 2011

  

2011

- SCHMITT, The senescence-host immune connection in cancer, (Ospite Pandolfi)

- ALIMONTI, Manipulation of senescence pathways for cancer therapy from experimental model to clinic (Ospite Pandolfi)

- KAIRBAAN HODIVALA DILKE, Dose matters and angiogenesis (Ospite Taverna)

- THOMAS THUM, Cardiovascular microRNAs: mechanism, therapeutic strategies and biomarker approaches

- PASCAL MEIER, Ubiquitin-mediated regulation of cell survival (Ospite Santoro)

- JUDITH VARNER, PI3Kgamma and tumor inflammation (Ospite Hirsch)

- BIRCHMEIER, Wnt beta- catenin and Met signalling in stem and cancer stem cells (Ospite Tarone)

- PFEIFER, The cGMP/protein kinase G in fat tissue (Ospite Hirsch)

- PANDOLFI, The ceRNA hypothesis and the non-coding evolution in cancer research and therapy (Ospite Matullo)

- PFEIFER, Role of cGMP/protein kinase G in fat tissue (Ospite Hirsch)

- CHIARLE, Eventi molecolari che precedono e seguono una traslocazione cromosomica (Ospite Tarone)

2010

- STREULI, The essential role of Integrins in controlling development and epithelial funcion in mammary gland (ospite Defilippi)

- PANDOLFI, New advances on NPM and its mutated NPMc+ version in tumorigenesis (ospite Tarone)

- PANDOLFI, A new microRNA proto-oncogenic network that downregulates PTEN in cancer (ospite Tarone)

- OTTENSMEIERIC, DNA vaccines against cancer: the Southampton perspective (ospite Forni)

- BAZZONI, A regulatory circuitry involving miR-9 and Nf-Kb controls neutrophils and monocytes activation by LPS (ospite Poli)

-SCHMID, Tumor inflammation and progression depend on PI3Kgamma mediated activation of Integrin beta1 (ospite Hirsch)

- MERICSKAY, SRF: a master regulator of cytoskeletal genes (ospite Tarone)

- HYNES, Targeting receptor tyrosine kinases in breast cancer (ospite Taverna)

- GINESTIER, Breast cancer stem cells (ospite Cabodi)

- TORTI, Recent advancements in platelet Integrin signaling: the role of PI3K-beta and PYK2 (ospite Hirsch)

 - “Cellular senescence, in aging, stem cell biology, tumor suppression and therapy”, tenuto dal Prof. Pandolfi, della durata di 4 giorni (14-15, 18-19 Aprile 2011)